Scientific poster exhibition at the Swiss Biotech Day

ProgramPoster exhibitions

Poster exhibitions

Let your project speak for itself, all conference long.

When
On display both days; one 45-minute poster presentation each day
Where
Poster exhibition areas on level 1
Format
Printed A0 portrait poster, printed and mounted at the venue
Who presents
Swiss R&D biotech companies only
Cost
Free for Swiss Biotech Association members, CHF 500 plus VAT for non-members

About the format

Poster exhibitions offer Swiss R&D biotech companies an excellent opportunity to showcase their research, innovation and value proposition to a global audience of investors, pharma partners and talent.

Attendees explore the posters throughout the conference. Posters support outreach and scouting for the whole two days, and during the two dedicated poster sessions company representatives are available at their posters to discuss their work.

Delegate reading the conference guide
Posters are listed in the conference guide and on the website.

Why take part

What poster exhibitions offer

  1. Showcase your innovation

    Present your value proposition and latest business developments to the people who scout for them.

  2. High-quality conversations

    Two dedicated sessions bring genuinely interested attendees to your poster.

  3. Create opportunities

    Initiate partnerships, collaborations or investment discussions at an early stage.

Swiss innovation spotlight

R&D posters from the Swiss Biotech Day 2026

Swiss biotech companies present their research, pipeline and partnering opportunities as posters, on display for the whole conference and discussed in two 45-minute poster sessions. A couple of examples from the 2026 series, with a link to each company.

  • Poster by Metys Pharmaceuticals on dimiracetam for chemotherapy-induced neuropathy

    Metys Pharmaceuticals

    Stop Cancer Patients from Stopping Treatment

    Dimiracetam, a transformative therapy for the acute sensory neuropathy caused by chemotherapy.

    metys-pharma.ch
  • Poster by Onward Therapeutics on its multi-modality oncology pipeline

    Onward Therapeutics

    Advancing a Multi-Modality Pipeline Against Cancer Resistance

    Bispecific antibodies, an allogeneic NK cell therapy and small molecules to overcome resistance in cancer care.

    onward-therapeutics.com
  • Poster by Synendos Therapeutics on selective endocannabinoid reuptake inhibitors

    Synendos Therapeutics

    Restoring Brain Function in CNS Disorder

    A phase 2 clinical-stage company using first-in-class selective endocannabinoid reuptake inhibitors to restore function in neuropsychiatric patients.

    synendos.com

Your story matters

Help showcase the full strength of the Swiss biotech ecosystem with your poster at the Swiss Biotech Day.